1. Home
  2. CTW vs ADAG Comparison

CTW vs ADAG Comparison

Compare CTW & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTW

CTW Cayman Class A Ordinary Shares

N/A

Current Price

$1.46

Market Cap

93.6M

Sector

Technology

ML Signal

N/A

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.26

Market Cap

90.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTW
ADAG
Founded
2013
2011
Country
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.6M
90.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTW
ADAG
Price
$1.46
$3.26
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
53.9K
253.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3,688.61
Revenue Next Year
N/A
$17.39
P/E Ratio
$21.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$1.30
52 Week High
$4.88
$3.46

Technical Indicators

Market Signals
Indicator
CTW
ADAG
Relative Strength Index (RSI) 41.89 68.34
Support Level $1.10 $2.70
Resistance Level $1.99 $3.19
Average True Range (ATR) 0.21 0.43
MACD 0.02 0.04
Stochastic Oscillator 34.19 85.77

Price Performance

Historical Comparison
CTW
ADAG

About CTW CTW Cayman Class A Ordinary Shares

CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: